Clinical Trial Update: Use of Nesiritide in the Management of Acute Diastolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update on nesiritide for acute diastolic heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diastolic Heart Failure
• Heart Disease
• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Heart Failure, Cardiovascular Disease | Phase 4 | Status: TERMINATED